Q32 Bio Inc. (QTTB)
NASDAQ: QTTB · IEX Real-Time Price · USD
17.04
+0.87 (5.38%)
At close: Mar 28, 2024, 4:00 PM
16.70
-0.34 (-2.00%)
After-hours: Mar 28, 2024, 5:24 PM EDT

Q32 Bio Income Statement

Millions USD. Fiscal year is Jan - Dec.
Year 20232022202120202019201820172016
Revenue
1.163.2133.972.71.675.3200
Revenue Growth (YoY)
-63.97%-90.56%1157.25%62.18%-68.70%---
Gross Profit
1.163.2133.972.71.675.3200
Selling, General & Admin
31.2638.1436.8432.5722.2117.38.284.31
Research & Development
6298.3593.09100.3989.447.9521.385.69
Other Operating Expenses
9.330000000
Operating Expenses
102.59136.49129.92132.97111.6165.2529.6610
Operating Income
-101.43-133.28-95.95-130.26-109.94-59.93-29.66-10
Other Expense / Income
11.53-128.99-0.19-1.57-6.03-4.350.33-1.95
Pretax Income
-112.96-4.29-95.76-128.69-103.92-55.58-29.99-8.05
Income Tax
00.72000000
Net Income
-112.96-5.01-95.76-128.69-103.92-55.58-29.99-8.05
Shares Outstanding (Basic)
33332200
Shares Outstanding (Diluted)
33332200
Shares Change
0.76%3.83%20.41%9.01%47.51%1051.55%30.46%-
EPS (Basic)
-35.10-1.62-31.14-50.40-44.46-35.10-217.80-76.14
EPS (Diluted)
-35.10-1.62-31.14-50.40-44.46-35.10-217.80-76.14
Free Cash Flow
-95.9-114.95-112.15-98.07-113.19-67.54.52-10.47
Free Cash Flow Per Share
-29.85-36.05-36.52-38.45-48.38-42.5532.82-99.19
Gross Margin
100.00%100.00%100.00%100.00%100.00%100.00%--
Operating Margin
-8774.13%-4154.64%-282.44%-4820.98%-6599.22%-1126.01%--
Profit Margin
-9771.71%-156.02%-281.90%-4762.92%-6237.45%-1044.29%--
Free Cash Flow Margin
-8296.19%-3583.10%-330.13%-3629.35%-6794.18%-1268.34%--
EBITDA
-110.32-1.69-86.22-119.79-97.6-54.29-29.31-7.81
EBITDA Margin
-9543.08%-52.71%-253.80%-4433.38%-5858.22%-1020.07%--
Depreciation & Amortization
2.642.69.548.96.321.290.680.24
EBIT
-112.96-4.29-95.76-128.69-103.92-55.58-29.99-8.05
EBIT Margin
-9771.71%-133.73%-281.90%-4762.92%-6237.45%-1044.29%--
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).